This Micro Cap Soared On Key Announcement

By: Dylan Sikes – AllPennyStocks.com News

Tuesday, January 14, 2025

A Virginia-based medical tech company found a crazy amount of success on Tuesday following an announcement that the company is advancing its research used to assess a patient’s brain age (an estimation of the biological age of a person’s brain) via its FDA-cleared BNA technology platform.

Traders were quick to buy up share of Firefly Neuroscience Inc. (Nasdaq:AIFF) following the news, with shares of the micro cap reaching up to $5.80/share (+205.26%$) at the early session high. This move could be an indication that this stock is breaking out of the multi-month downtrend it has been stuck in.

Firefly Neuroscience Inc. is an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA™) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has built a comprehensive database of brain wave tests, securing patent protection, and achieving FDA clearance. The Company is now launching BNA™ commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use.

Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.